Jill Ann Howe insider trades
Open-market stock purchases and sales by Jill Ann Howe, Chief Financial Officer at Lineage Cell Therapeutics, Inc, from SEC Form 4 filings since Nov 3, 2021.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +68%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 5, 2026 | LCTX Lineage Cell Therapeutics, Inc | Bought (not open market) | — |